Amgen Inc: (BATS: AMGN)

(U.S: BATS) As of Nov 26, 2014 10:23 AM ET

 Add to portfolio

$163.27 USD

+1.03 (0.64%)

Volume: 387,480

Zacks Rank : 1-Strong Buy [?] 1        

Brokerage Reports

Search for reports:

0 items in cart

AMGEN INC [AMGN]

Reports for Purchase

Showing records 1 - 20 ( 190 total )

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 1

10/27/2014

Company Report

Pages: 12

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 2

10/22/2014

Industry Report

Pages: 5

Biotechnology: September Script Data Offers a Last Look at Q314 Ahead of Reporting

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 3

10/13/2014

Industry Report

Pages: 9

Biotechnology - All Things Considered, Anticipate a Solid Q314

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 4

09/24/2014

Industry Report

Pages: 7

August Script Data Gives a Better Look at Q314 Commercial Progress

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 5

09/08/2014

Company Report

Pages: 14

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 6

08/20/2014

Industry Report

Pages: 7

Biotechnology: July Script Data Offers First Look at Q314 Progress

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 7

07/31/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 8

07/30/2014

Company Report

Pages: 8

Inventory Helps Q214 Beat, but Restructuring Likely Grabs More Attention

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 9

07/23/2014

Industry Report

Pages: 7

June Institutional Script Data Posts; Just Ahead of Q214 Reporting

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 10

07/17/2014

Industry Report

Pages: 15

Biotechnology -Looking for a Q214 Rebound

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 50.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 11

06/25/2014

Industry Report

Pages: 6

Biotechnology -May Institutional Data Gives a Look into Q214

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 12

05/21/2014

Industry Report

Pages: 7

Biotechnology - First Look at Q214 with April Script Data

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 13

05/06/2014

Company Report

Pages: 11

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 14

04/23/2014

Company Report

Pages: 8

A Q1 Miss Usually No Big Deal, but This One More Bothersome

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 15

04/23/2014

Industry Report

Pages: 6

Just in Time - March Script Data Offers One More Glimpse At Q114

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 16

04/23/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 17

03/31/2014

Industry Report

Pages: 5

PCSK9 on Full Display at ACC, No Surprises Here

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 18

03/19/2014

Industry Report

Pages: 6

February Script Data Tempered by Fewer Selling Days

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 19

02/28/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 20

01/30/2014

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party